Analysts' Recommendation: Buy 30 Days Ago: Buy Analysts' Target: $49 Analysts' Targets HSBC Securities $49 Add Thursday, June 12, 2008 BusinessWeek Rankings Best Global Brands Best Global Brands 2006 #43 2005 #43 Novartis AG provides healthcare solutions that address the needs of patients and societies worldwide. Its Pharmaceuticals division researches, develops, manufactures, distributes, and sells pharmaceuticals in therapeutic areas, including cardiovascular and metabolism; oncology and hematology; neuroscience; respiratory; infectious diseases, transplantation, and immunology; ophthalmics, dermatology, gastrointestinal, and urinary; and arthritis and bone. The company’s Vaccines and Diagnostics division focuses on the development of preventive vaccine treatments and diagnostic tools. It offers meningococcal, pediatric, and travel vaccines; and blood testing and molecular diagnostics for preventing the spread of infectious diseases. Novartis’ Sandoz division develops, produces, and markets drugs, as well as pharmaceutical and biotechnological active substances. Its Consumer Health division includes three units: Over-The-Counter Medicines (OTC), Animal Health, and CIBA Vision. OTC unit offers self medications; Animal Health unit provides veterinary products for farm and companion animals; and CIBA Vision unit markets contact lenses, lens care products, and ophthalmic products. Novartis has strategic alliance with Morphosys AG for the discovery and development of biopharmaceuticals. The company was founded in 1895 and is headquartered in Basel, Switzerland.
$56.83 (07/12/08)
